Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionKovack Advisors, Inc.
Latest Disclosed Ownership20,172 shares
Latest Disclosed Value $ 2,069,045
Kovack Advisors, Inc. reports 0.59% increase in ownership of ABL / Abbott Laboratories

On May 12, 2026 - Kovack Advisors, Inc. filed a 13F-HR form disclosing ownership of 20,172 shares of Abbott Laboratories (DE:ABL) valued at $1,791,677 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 17, 2026 disclosing 20,053 shares of Abbott Laboratories. This represents a change in shares of 0.59% during the quarter. The current value of the position is $1,517,338 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 20,172 119 0.59 2,069 -17.64 0.1104
2026-02-17 2025-12-31 13F/A-1 ABBOTT LABS COM 002824100 20,053 13,812 221.31 2,512 200.84 0.1168
2026-02-12 2025-12-31 13F ABBOTT LABS COM 002824100 20,052 13,811 931 0.0713
2025-11-10 2025-09-30 13F ABBOTT LABS COM 002824100 6,241 -1,655 -20.96 836 -22.18 0.0787
2025-08-04 2025-06-30 13F ABBOTT LABS COM 002824100 7,896 -571 -6.74 1,074 -4.45 0.1053
2025-05-06 2025-03-31 13F ABBOTT LABS COM 002824100 8,467 -1,583 -15.75 1,123 -1.14 0.1189
2025-02-05 2024-12-31 13F ABBOTT LABS COM 002824100 10,050 1,306 14.94 1,137 14.06 0.1116
2024-11-05 2024-09-30 13F ABBOTT LABS COM 002824100 8,744 -226 -2.52 997 6.87 0.1056
2024-08-05 2024-06-30 13F ABBOTT LABS COM 002824100 8,970 121 1.37 932 -7.26 0.1026
2024-04-19 2024-03-31 13F ABBOTT LABS COM 002824100 8,849 1,656 23.02 1,006 27.05 0.1218
2024-02-02 2023-12-31 13F ABBOTT LABS COM 002824100 7,193 525 7.87 792 22.64 0.0940
2023-10-19 2023-09-30 13F ABBOTT LABS COM 002824100 6,668 345 5.46 646 -6.39 0.0901
2023-07-21 2023-06-30 13F ABBOTT LABS COM 002824100 6,323 -2,334 -26.96 689 -21.35 0.0883
2023-04-21 2023-03-31 13F ABBOTT LABS COM 002824100 8,657 1,253 16.92 877 7.88 0.1195
2023-02-22 2022-12-31 13F ABBOTT LABORATORIES ORD ORD 002824100 7,404 -755 -9.25 813 2.92 0.1188
2022-11-14 2022-09-30 13F ABBOTT LABORATORIES ORD ORD 002824100 8,159 -3,590 -30.56 789 -38.21 0.1159
2022-08-10 2022-06-30 13F ABBOTT LABORATORIES ORD ORD 002824100 11,749 -3,668 -23.79 1,277 -29.99 0.1685
2022-05-16 2022-03-31 13F ABBOTT LABORATORIES ORD ORD 002824100 15,417 926 6.39 1,824 -10.54 0.1874
2022-01-18 2021-12-31 13F ABBOTT LABORATORIES ORD ORD 002824100 14,491 -2,345 -13.93 2,039 2.51 0.1970
2021-11-03 2021-09-30 13F ABBOTT LABORATORIES ORD ORD 002824100 16,836 2,378 16.45 1,989 18.68 0.2162
2021-07-29 2021-06-30 13F ABBOTT LABORATORIES ORD ORD 002824100 14,458 -345 -2.33 1,676 -5.52 0.1908
2021-05-04 2021-03-31 13F ABBOTT LABORATORIES ORD ORD 002824100 14,803 -1,091 -6.86 1,774 1.95 0.2305
2021-01-14 2020-12-31 13F ABBOTT LABORATORIES ORD ORD 002824100 15,894 731 4.82 1,740 5.45 0.2504
2020-11-02 2020-09-30 13F ABBOTT LABORATORIES ORD ORD 002824100 15,163 521 3.56 1,650 23.23 0.2936
2020-07-31 2020-06-30 13F ABBOTT LABORATORIES ORD ORD 002824100 14,642 82 0.56 1,339 16.54 0.2607
2020-04-30 2020-03-31 13F ABBOTT LABORATORIES ORD ORD 002824100 14,560 -290 -1.95 1,149 -10.93 0.2654
2020-01-29 2019-12-31 13F ABBOTT LABORATORIES ORD ORD 002824100 14,850 983 7.09 1,290 11.21 0.2306
2019-10-31 2019-09-30 13F ABBOTT LABORATORIES ORD ORD 002824100 13,867 -429 -3.00 1,160 -3.49 0.2380
2019-08-14 2019-06-30 13F ABBOTT LABS COM COM 002824100 14,296 2,135 17.56 1,202 23.66 0.2748
2019-05-03 2019-03-31 13F ABBOTT LABS COM COM 002824100 12,161 -548 -4.31 972 5.77 0.2424
2019-02-06 2018-12-31 13F ABBOTT LABS COM COM 002824100 12,709 3,869 43.77 919 41.60 0.2687
2018-10-09 2018-09-30 13F ABBOTT LABS COM COM 002824100 8,840 3,188 56.40 649 88.12 0.1674
2018-08-01 2018-06-30 13F ABBOTT LABS COM COM 002824100 5,652 -3,722 -39.71 345 -38.61 0.0964
2018-05-15 2018-03-31 13F ABBOTT LABS COM COM 002824100 9,374 172 1.87 562 7.05 0.1410
2018-05-15 2017-12-31 13F/A-1 ABBOTT LABS COM 002824100 9,202 9,202 525 0.1327
2018-02-01 2017-12-31 13F ABBOTT LABS COM 002824100 10,175 581
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.